Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000149

Drug Information
SynonymsUNII-3YFV00531K; PDSP2_000932; SR-27897B; AC1L3TXG; PDSP1_000946; CHEMBL249973; C20H14ClN3O3S; SR 27897B; 1-((2-(4-(2-Chlorophenyl)thiazol-2-yl)aminocarbonyl)indolyl)acetic acid; LS-172957; NCGC00167729-01; 136381-85-6; SR-27897; SR 27897; 2-((4-(o-Chlorophenyl)-2-thiazolyl)carbamoyl)indole-1-acetic acid; SR27897; CID122077; 1H-Indole-1-acetic acid, 2-(((4-(2-chlorophenyl)-2-thiazolyl)amino)carbonyl)-; 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]acetic acid; L000575; BRD-K35629949-001-01-2; Lintitript
IndicationPancreatic Cancer, Obesity
[ICD9: 140-229, 157, 278   ICD10: C00-C96, C25, E66]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1=CC=C2C(=C1)C=C(N2CC(=O)O)C(=O)NC3=NC(=CS3)C4=CC=CC=C4Cl    
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 136381-85-6
PubChem Compound IDCID 122077.
PubChem Substance IDSID 698591.
TargetCholecystokinin type A (CCK-A) receptorAntagonist[1][2]
Ref 1A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin. Br J Pharmacol. 2008 Jul;154(5):1009-15. Epub 2008 Apr 21. To Reference
Ref 2A novel role for cholecystokinin: regulation of mesenteric vascular resistance. Regul Pept. 2004 Sep 15;121(1-3):145-53. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543